A Valence-Engineered Self-Cascading Antioxidant Nanozyme for the Therapy of Inflammatory Bowel Disease

Angew Chem Int Ed Engl. 2022 Jul 4;61(27):e202201101. doi: 10.1002/anie.202201101. Epub 2022 May 5.

Abstract

Antioxidant treatment strategy by scavenging reactive oxygen species (ROS) is a highly effective disease treatment option. Nanozymes with multiple antioxidant activities can cope with the diverse ROS environment. However, lack of design strategies and limitation of negative correlation for nanozymes with multiple antioxidant activities hindered their development. To overcome these difficulties, here we used ZnMn2 O4 as a model to explore the role of Mn valency at the octahedral site via a valence-engineered strategy, and found that its multiple antioxidant activities are positively correlated with the content of Mn4+ . Therefore, through this strategy, a self-cascading antioxidant nanozyme LiMn2 O4 was constructed, and its efficacy was verified at the cellular level and in an inflammatory bowel disease model. This work not only provides guidance for the design of multiple antioxidant nanozymes, but also broadens the biomedical application potential of multiple antioxidant nanozymes.

Keywords: Antioxidant; Reactive Oxygen Species; Self-Cascade Nanozyme; Spinel Oxide; Valence-Engineering Strategy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants* / pharmacology
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Reactive Oxygen Species

Substances

  • Antioxidants
  • Reactive Oxygen Species